BCRX FY 2007 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

BCRXBioCryst Pharmaceuticals, Inc.

$2B

FY 2007 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$71M+1046.8% YoY

Gross Profit

$71M100.0% margin

Operating Income

-$32M-45.3% margin

Net Income

-$29M-40.8% margin

EPS (Diluted)

$-0.89

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

$3.3B

Stock-Based Comp.

$5.7B

Balance Sheet

Total Assets

$143M

Total Liabilities

$78M

Stockholders' Equity

$65M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$71M	$6M	+1046.8%
Gross Profit	$71M	$6M	+1046.8%
Operating Income	-$32M	-$47M	+31.3%
Net Income	-$29M	-$44M	+33.4%